We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RINC
2951
DELISTED
AXS Real Estate Income ETF
RINC
$8.99K ﹤0.01%
395
– –
RAPT
2952
DELISTED
RAPT Therapeutics
RAPT
$8.88K ﹤0.01%
364
– –
SMTI icon
2953
Sanara MedTech
SMTI
$314M
$8.83K ﹤0.01%
313
– –
FHTX icon
2954
Foghorn Therapeutics
FHTX
$385M
$8.82K ﹤0.01%
1,534
– –
DLHC icon
2955
DLH Holdings
DLHC
$68.7M
$8.78K ﹤0.01%
+831
New +$9.37K
PAMT
2956
PAMT Corp
PAMT
$285M
$8.72K ﹤0.01%
502
– –
RQI icon
2957
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$8.67K ﹤0.01%
742
+90
+14% +$1.02K
DSP icon
2958
Viant Technology
DSP
$274M
$8.63K ﹤0.01%
874
– –
DSGN icon
2959
Design Therapeutics
DSGN
$901M
$8.61K ﹤0.01%
2,570
– –
IVVD icon
2960
Invivyd
IVVD
$202M
$8.55K ﹤0.01%
+7,770
New +$17.2K
CRDF icon
2961
Cardiff Oncology
CRDF
$76.6M
$8.52K ﹤0.01%
+3,838
New +$14.5K
FDEC icon
2962
FT Vest US Equity Buffer ETF December
FDEC
$1.36B
$8.51K ﹤0.01%
200
– –
MAPS
2963
DELISTED
WM TECHNOLOGY INC A
MAPS
$8.5K ﹤0.01%
+8,176
New +$8.98K
NC icon
2964
NACCO Industries
NC
$316M
$8.41K ﹤0.01%
304
– –
GLUE icon
2965
Monte Rosa Therapeutics
GLUE
$1.35B
$8.38K ﹤0.01%
2,241
– –
NAUT icon
2966
Nautilus Biotechnolgy
NAUT
$113M
$8.37K ﹤0.01%
3,575
– –
LNAI
2967
Lunai Bioworks
LNAI
$10.2M
$8.36K ﹤0.01%
+60
New +$8.18K
AVAH icon
2968
Aveanna Healthcare
AVAH
$2.46B
$8.35K ﹤0.01%
3,026
– –
COOK icon
2969
Traeger
COOK
$166M
$8.23K ﹤0.01%
69
– –
KLTR icon
2970
Kaltura
KLTR
$243M
$8.23K ﹤0.01%
6,855
– –
MPX
2971
DELISTED
Marine Products Corp
MPX
$8.21K ﹤0.01%
813
– –
GYRE icon
2972
Gyre Therapeutics
GYRE
$693M
$8.15K ﹤0.01%
+683
New +$9.37K
CRML icon
2973
Critical Metals Corp
CRML
$967M
$8.07K ﹤0.01%
+716
New +$7.54K
NREF
2974
NexPoint Real Estate Finance
NREF
$318M
$8.07K ﹤0.01%
588
– –
BNTX icon
2975
BioNTech
BNTX
$23.1B
$8.04K ﹤0.01%
100
– –
117 118
119
120 121

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.